RNA was extracted from whole blood, plasma, and tissue using RNeasy Protect Animal Blood, QIAamp Viral RNA Mini, and RNeasy Mini kits (Qiagen). Tissue samples were homogenized using a FastPrep®-24 homogenizer and Lysing Matrix D (MP Biomedicals). qPCR primers and probes ZIKV_1086, ZIKV_1162c, ZIKV_1107_P were synthesized by Integrated DNA Technologies [48 (link)]. Viral loads were quantified by qRT-PCR using the SuperScript III Platinum One-Step qRT-PCR Kit (Thermo Fisher) and a LightCycler 480 (Roche) instrument as previously described [10 (link)]. To determine the concentration of ZIKV RNA in a sample, a synthetic DNA fragment corresponding to the H/PF/2013 genome from positions 1086 to 1107 was amplified and subcloned into pCR4-TOPO (Thermo Fisher). RNA standards were synthesized using a MAXIscript T7/T3 Transcription Kit (Thermo Fisher), quantified by absorbance and Quant-iT Ribogreen RNA Assay Kit (Life Technologies), and serially diluted to generate in-run standard curves for qRT-PCR analysis. To quantify ZIKV NS1-antigenemia, plasma from guinea pigs was subjected to a Zika Virus NS1 ELISA (BioFront Technologies).
Free full text: Click here